Rocket Pharmaceuticals Inc (RCKT)
Stock-Based Compensation
$7.42M
Quarterly · Period ending: · USD
RCKT Stock-Based Compensation
Latest reported$7.42Mperiod ending
Latest reported$7.42Mperiod ending
RCKT Quarterly Stock-Based Comp ($3.00K → $7.42M)
Quarterly stock-based compensation
High-resolution chart · PNG
RCKT stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 7,419,000 | |
| 8,493,000 | |
| 6,112,000 | |
| 9,759,000 | |
| 10,857,000 | |
| 10,331,000 | |
| 11,088,000 | |
| 11,248,000 | |
| 11,332,000 | |
| 10,252,000 | |
| 0 | |
| 10,316,000 | |
| 10,245,000 | |
| 8,915,000 | |
| 0 | |
| 7,677,000 | |
| 7,369,000 | |
| 6,270,000 | |
| 7,037,000 | |
| 0 | |
| 0 | |
| 7,900,000 | |
| 6,070,000 | |
| 4,047,000 | |
| 4,489,000 | |
| 3,961,000 | |
| 3,359,000 | |
| 2,693,000 | |
| 4,139,000 | |
| 3,180,000 | |
| 2,821,000 | |
| 2,612,000 | |
| 2,786,000 | |
| 5,382,000 | |
| 1,548,000 | |
| 701,000 | |
| 162,000 | |
| 99,000 | |
| 931,000 | |
| 805,000 | |
| 687,000 | |
| 486,000 | |
| 448,000 | |
| 374,000 | |
| 194,000 | |
| 1,364,000 | |
| -177,000 | |
| 173,000 | |
| 2,000 | |
| 2,000 | |
| 3,000 |